AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
Financial Post ·
News Provided by Biotech Insider on behalf of MindWalk Holdings Corp. BOSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) — Biotech Insider News Commentary – For most of the past decade, the promise of AI in drug discovery was measured in designs: more candidate molecules, generated faster. The measure is changing. The companies building AI-native discovery platforms […]
Read More